Abstract
We read with great interest the article, 'Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic' [1]. This study's primary focus was to determine the efficacy of hospital resources' response and capability amid the coronavirus disease (COVID-19) outbreak and suspected consequences for patients with myocardial infarction that are eligible for percutaneous coronary intervention (PCI)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
